Macrophage- and lymphocyte-produced Th1 and Th2 cytokines in the tumour microenvironment.
Fridman
W H
WH
Laboratoire d'Immunologie Clinique, INSERM U255, Institut Curie, Paris.
Tartour
E
E
D000818:Animals; D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000503:physiopathology; D002294:Carcinoma, Squamous Cell / Q000276:immunology / Q000503:physiopathology; D005260:Female; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis* / Q000235:genetics; D020381:Interleukin-17 / Q000276:immunology; D007376:Interleukin-2 / Q000235:genetics / Q000627:therapeutic use; D015850:Interleukin-6 / Q000096:biosynthesis* / Q000235:genetics; D007680:Kidney Neoplasms / Q000276:immunology / Q000503:physiopathology; D008214:Lymphocytes / Q000276:immunology*; D008264:Macrophages / Q000276:immunology*; D008545:Melanoma / Q000276:immunology / Q000503:physiopathology; D009369:Neoplasms / Q000276:immunology* / Q000503:physiopathology; D012878:Skin Neoplasms / Q000276:immunology / Q000503:physiopathology; D018417:Th1 Cells / Q000276:immunology*; D018418:Th2 Cells / Q000276:immunology*; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000503:physiopathology
D020381:Interleukin-17; D007376:Interleukin-2; D015850:Interleukin-6; D007371:Interferon-gamma